Top line accelerating.
+6.3% YoY versus −2.0% prior. 3y CAGR +2.1%.
+6.3%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $23.2B
Fundamentals as of 2026-03-31
The Question
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
Yes — West Pharmaceutical Services, Inc.'s 18.1% ROE ranks above the S&P 500 median, and D/E 0.37 stays within healthy bounds.
Financial story
Yes — West Pharmaceutical Services, Inc.'s 18.1% ROE shows strong capital efficiency, and its 0.37 debt-to-equity stays within healthy bounds.
Bottom line: WST currently has no legendary investor models qualifying — see /stock/WST/valuation for the per-model breakdown, but earns a C sector grade (48/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
+6.3% YoY versus −2.0% prior. 3y CAGR +2.1%.
+6.3%Net margin 16.1% versus 17.0% prior (−1.0pp). Operating 20.1%.
16.1%P/E 42.0x — 3% above the 5y median of 40.6x. Forward 38.1x hints at EPS expansion next year.
42.0xHow does WST compare?
WST is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate WST a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
West Pharmaceutical Services, Inc.'s fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
WST trades at 40.9x earnings. Sector context and per-investor signals are in the valuation tab.
WST and LH differ on P/E, ROE, and revenue growth. See the full WST vs LH compare matrix.
Investor verdicts for WST are listed in the valuation tab. Per-model fair value and reasoning are in the valuation tab.
See exactly where WST ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingWST sits at #61 in Healthcare with a C grade (48/100).